Literature DB >> 15951553

Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia.

O Buchel1, T Roskams, B Van Damme, F Nevens, J Pirenne, J Fevery.   

Abstract

A male patient with portal hypertension, portal vein thrombosis, spontaneous splenorenal shunt formation, and encephalopathy, thought to have post-hepatitis B cirrhosis, is described. His condition deteriorated and necessitated liver transplantation. In the explant liver, nodular regenerative hyperplasia with pronounced vascular lesions both in portal venules and in arterioles was found instead of classical cirrhosis. Two years post-transplant he developed bilateral ischaemic femur head necrosis. The three disorders (portal vein thrombosis, nodular regenerative hyperplasia, and ischaemic hip necrosis) seemed to be due to a common vasculopathy induced by hyperhomocyteinaemia. Genetic studies showed that he carried a mutation in the gene encoding for formation of methylenetetrahydrofolate reductase. Treatment with folic acid combined with pyridoxine (vitamin B6) and cyanocobalamin (vitamin B12) normalised his serum homocysteine levels.

Entities:  

Mesh:

Year:  2005        PMID: 15951553      PMCID: PMC1774592          DOI: 10.1136/gut.2004.055921

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

Review 1.  Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature.

Authors:  R M Morlà; M Ramos-Casals; M García-Carrasco; R Cervera; J Font; M Bruguera; J Rojas-Rodríguez; M Ingelmo
Journal:  Lupus       Date:  1999       Impact factor: 2.911

2.  The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head.

Authors:  Charalampos G Zalavras; Konstantinos N Malizos; Eleni Dokou; George Vartholomatos
Journal:  Haematologica       Date:  2002-01       Impact factor: 9.941

3.  Bilateral femoral avascular necrosis in a man with psoriasis: responsibility of topical corticosteroids and role of cyclosporine.

Authors:  S Reichert-Pénétrat; P Tréchot; A Barbaud; P Gillet; J L Schmutz
Journal:  Dermatology       Date:  2001       Impact factor: 5.366

4.  Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.

Authors:  G Schnyder; M Roffi; R Pin; Y Flammer; H Lange; F R Eberli; B Meier; Z G Turi; O M Hess
Journal:  N Engl J Med       Date:  2001-11-29       Impact factor: 91.245

5.  Nodular regenerative hyperplasia of the liver and primary Sjögren's syndrome.

Authors:  I González-Alvaro; L Carmona-Ortell; A Amigo-Etxenagusia; S Castañeda Sanz
Journal:  J Rheumatol       Date:  1994-01       Impact factor: 4.666

Review 6.  Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.

Authors:  I R Wanless
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

7.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

8.  Homocysteine levels and the risk of osteoporotic fracture.

Authors:  Joyce B J van Meurs; Rosalie A M Dhonukshe-Rutten; Saskia M F Pluijm; Marjolein van der Klift; Robert de Jonge; Jan Lindemans; Lisette C P G M de Groot; Albert Hofman; Jacqueline C M Witteman; Johannes P T M van Leeuwen; Monique M B Breteler; Paul Lips; Huibert A P Pols; André G Uitterlinden
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

9.  Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.

Authors:  A Pathare; S Alkindi; T Albalushi; R Bayoumi; D Dennison; S Muralitharan
Journal:  Clin Lab Haematol       Date:  2004-04

10.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

View more
  7 in total

Review 1.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

2.  Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Authors:  G Vernier-Massouille; J Cosnes; M Lemann; P Marteau; W Reinisch; D Laharie; G Cadiot; Y Bouhnik; M De Vos; A Boureille; B Duclos; P Seksik; J-Y Mary; J-F Colombel
Journal:  Gut       Date:  2007-05-15       Impact factor: 23.059

Review 3.  Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

Authors:  Marek Hartleb; Krzysztof Gutkowski; Piotr Milkiewicz
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

4.  Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.

Authors:  Berrie Meijer; Melek Simsek; Hans Blokzijl; Robert A de Man; Minneke J Coenraad; Gerard Dijkstra; Carin Mj van Nieuwkerk; Chris Jj Mulder; Nanne Kh de Boer
Journal:  United European Gastroenterol J       Date:  2016-11-16       Impact factor: 4.623

5.  Avascular Necrosis of Femoral Head: A Metabolomic, Biophysical, Biochemical, Electron Microscopic and Histopathological Characterization.

Authors:  Aswath Narayanan; Prakash Khanchandani; Roshan M Borkar; Chandrashekar Reddy Ambati; Arun Roy; Xu Han; Ritesh N Bhoskar; Srinivas Ragampeta; Francis Gannon; Vijaya Mysorekar; Balasubramanyam Karanam; Sai Muthukumar V; Venketesh Sivaramakrishnan
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

6.  Portal Cavernoma Mimicking Pancreatic Malignancy.

Authors:  Vivian M Ussui; Lavinia Goldstein; Enrico Souto; Cynthia Levy
Journal:  ACG Case Rep J       Date:  2018-02-28

Review 7.  What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors.

Authors:  Ashish Goel; Banumathi Ramakrishna; Uday Zachariah; K G Sajith; Deepak K Burad; Thomas A Kodiatte; Shyamkumar N Keshava; K A Balasubramanian; Elwyn Elias; C E Eapen
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.